Recall Record

East Brunswick, NJ, United States

UNICHEM PHARMACEUTICALS USA INC recalls

9 recalls recorded since 2018, most recently on 13 April 2026. 4 are listed as ongoing. Status and classification are as published by the FDA.

Recalls9
Ongoing (FDA)4
Terminated or completed5
Class I (FDA)1

Ongoing Class III Drugs

Recall started
13 April 2026
Reason
Subpotent drug
Distribution
USA Nationwide
Initiated
Voluntary: Firm initiated
Recall number
D-0511-2026

Ongoing Class II Drugs

Recall started
21 January 2026
Reason
cGMP Deviations: recall due to not meeting the N-Nitroso Bisoprolol impurity specification limits.
Distribution
US Nationwide and PR.
Initiated
Voluntary: Firm initiated
Recall number
D-0301-2026

Ongoing Class III Drugs

Recall started
21 January 2026
Reason
Tablets/Capsules Imprinted with Wrong ID
Distribution
Nationwide
Initiated
Voluntary: Firm initiated
Recall number
D-0306-2026

Ongoing Class I Drugs

Recall started
27 August 2025
Reason
Labeling: Label Mix Up; Bottles of Meloxicam USP, 7.5mg, 90-count tablets (yellow in color), were labeled as Cyclobenzaprine Hydrochloride Tablets USP, 10 mg 90-count tablets (blue in color).
Distribution
Nationwide within the U.S.A
Initiated
Voluntary: Firm initiated
Recall number
D-0655-2025

Terminated Class III Drugs

Recall started
19 September 2022
Terminated
2 March 2023
Reason
Product mix-up:0.2 mg strength Clonidine Hydrochloride Tablets, USP in a 100-count bottle of 0.3 mg strength Clonidine Hydrochloride Tablets,
Distribution
Distributed Nationwide in the USA
Initiated
Voluntary: Firm initiated
Recall number
D-1541-2022

Terminated Class III Drugs

Recall started
25 October 2021
Terminated
12 October 2022
Reason
Discoloration
Distribution
Nationwide within the United States
Initiated
Voluntary: Firm initiated
Recall number
D-0255-2022

Terminated Class III Drugs

Recall started
26 May 2020
Terminated
8 January 2021
Reason
Failed Impurities/Degradation Specifications: potential migration of benzophenone at very low level into the product from container.
Distribution
Nationwide within the United States
Initiated
Voluntary: Firm initiated
Recall number
D-1291-2020

Terminated Class III Drugs

Recall started
29 January 2020
Terminated
8 January 2021
Reason
Failed Impurities/Degredation Specifications: This recall is initiated as a precautionary measure due to potential migration of Benzophenone at very low level into product from container label.
Distribution
Distributed Nationwide in the US
Initiated
Voluntary: Firm initiated
Recall number
D-0829-2020

Terminated Class II Drugs

Recall started
19 December 2017
Terminated
12 September 2018
Reason
Cross Contamination With Other Products: metronidazole powder was found in one bottle of Divalproex Sodium.
Distribution
Product was distributed nationwide in the USA.
Initiated
Voluntary: Firm initiated
Recall number
D-0228-2018

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.